Varian Medical Systems Reports Results for Second Quarter of Fiscal...(5.4 1075.5 1004.4 Oncology Sys...),Health
Navigation Links
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009
Date:4/29/2009
5.4 1,075.5 1,004.4 Oncology Systems 434.2 413.1 861.8 798.8 X-Ray Products 68.8 83.0 159.9 158.1 Other 21.2 19.3 53.8 47.5 Order backlog $1,901.0 1,690.3 1,901.0 1,690.3 Revenues $553.6 518.4 1,062.3 969.6 Oncology Systems 444.6 421.2 842.8 781.5 X-Ray Products 85.8 74.8 171.9 144.9 Other 23.2 22.4 47.6 43.2 Cost of revenues $313.2 306.8 602.9 566.9 Gross margin 240.4 211.6 459.4 402.7 As a percent of revenues 43.4% 40.8% 43.2% 41.5% Operating expenses Research and development 37.0 31.9 74.0 60.8 Selling, general and administrative 81.1 75.1 164.4 150.2 Operating earnings 122.3 104.6 221.0 191.7 As a percent of revenues 22.1% 20.2% 20.8% 19.8% Interest income/(expense), net (0.4) 1.6 1.0 3.1 Earnings from continuing operations before taxes 121.9 106.2 222.0 194.8 Taxes on earnings 42.6 33.3 73.1 63.7 Earnings from continuing operations 79.3 72.9 148.9 131.1 As a percent of revenues 14.3% 14.1% 14.0% 13.5% Loss from discontinued operations - net of taxes (1) (11.5) (1.6) (12.3) (4.3) Net earnings $67.8 71.3 136.6 126.8 Net earnings (loss) per share - basic: Continuing operations $0.64 0.58 1.20 1.05 Discontinued
'/>"/>
| SOURCE Varian Medical Systems, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Varian, Inc. Reports Second Quarter 2009 Results
2. Worlds largest DNA scan for autism uncovers new gene variant for disorder
3. MCG participating in national study to identify genetic variants in schizophrenia
4. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
5. Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery
6. Genetic variants predict recurrence of bladder cancer, patient survival
7. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
8. Chemo Combo Shows Promise Against Ovarian Cancer
9. Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
10. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China
11. Gene Variant Tied to Schizophrenia
Post Your Comments:
(Date:11/23/2009)... The #1 Luxury Auction Company, E... Mansion in the exclusive community of Cherry Hill...r 3, 2009. , Denver, Col...uxurious home of Barbara Fentress, located in Cher...ediately and keenly aware that no details were ove...
(Date:11/22/2009)...ein known to stimulate blood vessel growth has now...wth in the development of polyps that characterize...y by Johns Hopkins researchers suggests. The findi...vel therapies to treat this form of the disease, w... Chronic sinusitis, a constant irritation and swel...
(Date:11/22/2009)...INGTON, D.C. November 18, 2009 -- When people have...tes, which enter the body from the saliva of a mos...to red blood cells. Inside the blood cells, the pa...e proteins on the cell surface that change the phy...Experiments show that infected red blood cells are...
(Date:11/22/2009)... HealthSmart, an innovative healt...hat it has successfully completed a recapitalizati...’s other lenders. Silver Point Capital, L.P... Connecticut. This recapitalization allows the Co...iness strategy. , , (PRW...
(Date:11/21/2009)..., WASHINGTON, Nov. 21 ...ment after the Senate voted to begin full debate o...o: http://www.newscom.com/cgi-bin/prnh/20080519/D...istoric step on the road to enacting health insura...le, senators will now have an opportunity to debat...
Breaking Medicine News(10 mins):Health News:Barbara Fentress, Designer of the Denver International Airport and Convention Center, Offers Her Private Mansion at Absolute Auction 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:Measuring and modeling blood flow in malaria 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2[0] Barbara Fentress, Designer of the Denver International Airport and Convention Center, Offers Her Private Mansion at Absolute Auction[0] Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps[0] Measuring and modeling blood flow in malaria[1] HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman [0] Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation
...k of knowledge of health risks posed by long-term...) -- As cell phone technology and use continues to...s known about the potential health risks associate...subject to high occupational exposure -- the repor...
...Researchers at the University of Pennsylvania Scho...hemical cargo in nerve cells react differently whe...tant role in Alzheimers disease. , Dynein and ki...d bump to regulate protein traffic, the group foun...
... How to Safely Enhance Athletic Performance, LAKE...e,for athletes, coaches, trainers and parents, the...ement.com ) aims to provide individuals with infor... Informed-Choice LLC, a,not-for-profit partnership...
...an. 17 Following is a,media statement attributabl... New Jersey Hospital Association:, "NJHA applauds...t,Safety Initiative report. This is a valuable doc...ement efforts. The confidential reporting and,coll...
...nwide Campaign Challenging U.S. to Close the Gaps ...al, COLUMBUS, Ohio, Jan. 17 On Tuesday, January ...Cure will host two events to,launch Ohio,s partici...an others., (Logo: http://www.newscom.com/cgi-bi...
...Jan. 17 Immunosyn,Corporation (OTC Bulletin Board...formal "Proof of Concept Trial" for the biopharmac... Europe for treatment of Diabetic Ulcers., The Bo...rtner and largest shareholder. Argyll Biotechnolog...
Other Medicine News:Health News:Report Urges More Research Into Cell Phones 2Health News:Report Urges More Research Into Cell Phones 3Health News:Alzheimer's molecule is a smart speed bump on the nerve-cell transport highway 2Health News:New Blog Provides Forum for Discussions on Supplement Safety 2Health News:Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 3Report Urges More Research Into Cell PhonesAlzheimer's molecule is a smart speed bump on the nerve-cell transport highwayNew Blog Provides Forum for Discussions on Supplement SafetyState's Patient Safety Report a Valuable Tool For Hospitals' Quality Improvement WorkSusan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast CancerImmunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
(Date:11/20/2009)...N.C., Nov. 20 Cornerston...pharmaceutical company focused on acquiring, devel...marily for the respiratory and related markets, to... from the Food and Drug Administration ("FDA") all...lephrine HCl 10 mg, Pyrilamine Maleate 16 mg) and ...
(Date:11/20/2009)...SBURG, Pa., Nov. 20 The...1N1 flu shots to members of priority groups that d...A total of 18 clinics are being held statewide on ...to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a....operate from 2 p.m. to 8 p.m. ,, Individuals i...
(Date:11/20/2009)...W YORK, Nov. 20 ,, Reportlinke...is available in its catalogue. ,, India Medica... ,, http://www.reportlinker.com/p0164658/Indi...to-2015.html#utm_source=prnewswire&utm_medium=...n ,, India Medical Equipment Market Analysis a...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Governor Pawlenty Targets Teachers Public Safety and Health Care 49135 1International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 1International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 2International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 3International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 4International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 5International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 6International Medical Device Maker 3B Four Executives Charged in Connection With Unlawful Clinical Trials 49133 7Mutual Protection Trust Earns Fourth A+ Rating From A M Best 49131 1Mutual Protection Trust Earns Fourth A+ Rating From A M Best 49131 2[0] Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal[0] Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available[0] Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015
...on Hospitals to Invest More Resources and Take,Agg...TON, Dec. 11 U.S. healthcare,facilities aren,t do...sistant Staphylococcus aureus (MRSA) infections, a...sionals released today., The online poll conducte...n Control (APIC) found that 59 percent of those re...
...-day Dosing Schedules Appear Similar to Seven-Day ...nce, Hematologic Improvement ...e 49th American Society of Hematology (ASH) Meetin...: PHRM ) today announced interim data from a Phas...ve-day dosing schedules for Vidaza(R),(azacitidine...
Other Medicine Technology:Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 2Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6Alpina Total Knee Prosthesis
...The UC-Plus Solution knee is the state of the art ...cement. Geometry of the articular surfaces does no...natomical variations, and achieves a wide area of ... Large, uninterrupted pockets of cement create a h...
RT-Plus Solution
Total Condylar Knee System
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |